Hambi, I agree about the Ah-Chew products. I had a quick look back at the BGWL update BN and the two products are listed there. More importantly though, the note also said,
"Dedicated sales and existing distribution contracts. BioProgress’s
acquisition of airPharma extends to the three existing distribution agreements
with the three main distributors in the US: Cardinal Health, McKesson and
Amerisource Bergen.
..when referring to the AirPharma products so these two new products will be quickly and easily pushed down these sales, marketing and distribution channels. The bottom line to that story is increased revenues in a very short space of time over and above the known revenues of the existing AirPharma products.
Revenues->profits....I love those word!
EDIT: Goldrush...exactly...they have no shortage of manufacturing space which we can negotiate to use.